|

Inclisiran Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: KJX839, Leqvio

Pipeline

Phase 3: 4

Top Sponsors

  • Novartis Pharmaceuticals3
  • Icahn School of Medicine at Mount Sinai1

Indications

  • Heart Disease4
  • Familial Hypercholesterolemia - Heterozygous1
  • Familial Hypercholesterolemia - Homozygous1
  • Atherosclerotic Cardiovascular Disease1
  • Acute Coronary Syndrome1

San Francisco, California2 trials

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

UC San Francisco Medical Center

Phase 3
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

UC San Francisco Medical Center

Phase 3

Other1 trial

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Phase 3

New York, New York1 trial

The Prevent Coronary Artery Disease Trial

Mount Sinai Fuster Heart Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.